Corpus Intelligence IC Memo — KINDRED HOSPITAL ST. LOUIS 2026-04-26 08:03 UTC
IC Memo — KINDRED HOSPITAL ST. LOUIS
Investment Committee Memorandum | MO | 98 beds | Grade C | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KINDRED HOSPITAL ST. LOUIS

CCN 262010 | ST. LOUIS CITY, MO | 98 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KINDRED HOSPITAL ST. LOUIS is a 98-bed under-performing / distressed in ST. LOUIS CITY, MO with $34.0M in net patient revenue and a -8.1% operating margin. The hospital serves a payer mix of 25.3% Medicare, 18.8% Medicaid, and 55.9% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.1% to -0.7% (+736bps).

Net Revenue HCRIS$34.0M
Current EBITDA COMPUTED$-2.7M
Operating Margin COMPUTED-8.1%
Occupancy HCRIS49.8%
Revenue / Bed COMPUTED$347K
Net-to-Gross HCRIS19.5%
Distress Probability ML51.8%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
42
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -8.1% places it below the state median. Among 42 size-comparable peers (49-196 beds), the median margin is -1.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (49-196), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KINDRED HOSPITAL ST. LOUIS (Target)MO98$34.0M-8.1%
PHELPS COUNTY REGIONAL MEDICALMO196$270.3M33.1%
LAKE REGIONAL HEALTH SYSTEMMO105$226.8M-2.7%
HANNIBAL REGIONAL HOSPITALMO86$226.2M-6.8%
SSM HEALTH ST CLARE HOSPITALMO180$225.5M2.8%
CAPITAL REGION MEDICAL CENTERMO100$224.0M-17.7%
BARNES JEWISH WEST COUNTY HOSPMO68$221.1M4.9%
COX MEDICAL CENTER BRANSONMO144$217.3M-0.8%
SSM HEALTH ST. JOSEPH HOSPITALMO179$208.4M1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$714K+210bp18mo
Cost to Collect4.5%2.5%$680K+200bp12mo
Denial Rate Reduction12.0%6.5%$673K+198bp12mo
A/R Days Reduction5200.0%3800.0%$414K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$714K
Cost to Collect
$680K
Denial Rate Reduction
$673K
A/R Days Reduction
$414K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.5M
Current EBITDA$-2.7M
+ RCM Uplift+$2.5M
Pro Forma EBITDA$-242K
Current Margin-8.1%
Pro Forma Margin-0.7%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.2M$6.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.2M$6.2M0.00x-100.0%
Bull Case9.0x11.0x$-3.8M$13.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.8M$13.2M0.00x-100.0%
Bear Case11.0x10.0x$-4.6M$-4.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.6M$-6.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 51.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 49-196 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-17.8% / P50=-1.1% / P75=11.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.